Dear customers, we would like to share with you the great news on the decision of the European Commission (14 Oct 2021) extending the deadlines for the implementation of the new IVDR (Regulation No. 2017/746) in order to avoid disruption of the supply of in vitro medical devices. According to the risk classes of IVD devices, the new terms are proposed according to the following table:
In Vitro Diagnostic Medical Devices Regulation (europa.eu) md_2017-746-regulation_2021-amendment_en.pdf (europa.eu)
Currently, Dr. Viktor Cerny and and Dr. Jiri Hrdy, together with their colleagues have published a paper Lower Functional and Proportional Characteristics of Cord Blood Treg of Male Newborns Compared with Female Newborns.
Today we introduce one rat and two mouse monoclonal antibody clones, that have been added to our portfolio: Anti-galectin 3 (clone M3/38), anti-human CD270 (clone CW10), and anti-HLA-C (DT-9).